1-6 of 6
Ping-Chiao Tsai
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ublituximab (TGTX-1101), A Novel Anti-CD20 Monoclonal Antibody (mAb), Demonstrates Activity in Rituximab-Sensitive and Rituximab–resistant B Non-Hodgkin Lymphoma (B-NHL) Pre-Clinical In vitro and in Vivo models.

John Miller, Matthew J. Barth, MD, Cory Mavis, BSc, MSc, Ping-Chiao Tsai, PhD, Pavel Klener, Jr., MD, PhD, Francisco Hernandez-Ilizaliturri, MD, Myron S. Czuczman, MD
Journal: Blood
Blood (2012) 120 (21): 2756.
https://doi.org/10.1182/blood.V120.21.2756.2756
Published: 2012
Journal Articles

Ofatumumab (OFA) Is a Novel Anti-CD20 Monoclonal Antibody (mAb) with Improved Anti-Tumor Activity in Vitro and in Vivo in Mantle Cell Lymphoma (MCL) Pre-Clinical Models.

Matthew J. Barth, MD, Gopichand Pendurti, MD, Ping-Chiao Tsai, PhD, Cory Mavis, BSc, MSc, Pavel Klener, Jr., Myron S. Czuczman, MD, Francisco Hernandez-Ilizaliturri, MD
Journal: Blood
Blood (2012) 120 (21): 2757.
https://doi.org/10.1182/blood.V120.21.2757.2757
Published: 2012
Journal Articles

Ofatumumab, a Fully Human Monoclonal Antibody Targeting CD20, Demonstrates Activity Against and Potentiates the Anti-Tumor Activity of Chemotherapy Agents In Rituximab-Sensitive Cell Lines (RSCL), Rituximab-Resistant Cell Lines (RRCL), Lymphoma Xenografts, and Primary Tumor Cells Derived From Patients with B-Cell Non-Hodgkin Lymphoma (NHL)

Matthew Barth, MD, Francisco J. Hernandez-Ilizaliturri, MD, Cory Mavis, BSc, MSc, Ping-Chiao Tsai, John Gibbs, MD, George Deeb, MD, Myron S. Czuczman, MD
Journal: Blood
Blood (2010) 116 (21): 3917.
https://doi.org/10.1182/blood.V116.21.3917.3917
Published: 2010
Journal Articles

Rituximab Resistance Is Associated with Global Downregulation of CD20 and CD54 In B-Cell Lymphoma Cells: Implication of CD20 Signaling on CD54

Ping-Chiao Tsai, Peter Dvorak, Naveen Bangia, Scott Olejniczak, Myron S. Czuczman, MD, Francisco J. Hernandez-Ilizaliturri, MD
Journal: Blood
Blood (2010) 116 (21): 5077.
https://doi.org/10.1182/blood.V116.21.5077.5077
Published: 2010
Journal Articles

The Acquirement of Rituximab Resistance Is Associated with a Global Downregulation of CD54 in B-Cell Lymphoma Cells: The Potential Role of Adhesion Molecules in Rituximab Anti-Tumor Activity

Ping-Chiao Tsai, Naveen Bangia, Scott Olejniczak, Francisco J. Hernandez-Ilizaliturri, Myron Czuczman
Journal: Blood
Blood (2008) 112 (11): 2607.
https://doi.org/10.1182/blood.V112.11.2607.2607
Published: 2008
Journal Articles

Modulation of CD20 Expression in Rituximab-Sensitive (RSCL) and Rituximab Resistant Cell Lines (RRCL) Using IL-4 and Bryostatin-1.

Ping-Chiao Tsai, Pre-Doc, Francisco J. Hernandez-Ilizaliturri, MD, Scott H. Olejniczak, Pre-Doc, Bangia Naveen, PhD, Myron S. Czuczman, MD
Journal: Blood
Blood (2007) 110 (11): 2619.
https://doi.org/10.1182/blood.V110.11.2619.2619
Published: 2007